Plasma levels of atrial natriuretic peptide under acute hypoxia in normal subjects. 1989

A Kawashima, and K Kubo, and K Hirai, and S Yoshikawa, and Y Matsuzawa, and T Kobayashi
First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan.

To investigate whether the acute hypoxia can be a stimulus for atrial natriuretic peptide (ANP) secretion, plasma levels of ANP were determined under three different hypoxic conditions in six normal subjects. During 15% O2 breathing for 10 min, no significant change in plasma ANP level was observed. Severe hypoxia induced by 10% O2 breathing increased the mean pulmonary arterial pressure (Ppa) by 11.6 mm Hg within 10 min (P less than 0.01), accompanying a slight but significant rise in plasma ANP level of pulmonary artery (PA) from 24.3 +/- 5.3 to 28.2 +/- 4.6 pg/ml (P less than 0.05). There was a tendency for the ANP level of PA to rise under hypoxic hypobaria at 515 Torr for 10 min, followed by a decrease of that level during 100% O2 breathing under hypobaric condition. These changes, however, still remained in the normal range. No significant changes were observed both in right atrial pressure and in pulmonary capillary wedge pressure under any of the three hypoxic conditions. From these results we conclude that ANP can be released in response to the elevation of Ppa caused by acute hypoxia in normal subjects, but the changes in plasma ANP level may be too small to play a significant physiological role in hemodynamic responses to acute hypoxia.

UI MeSH Term Description Entries
D008297 Male Males
D009320 Atrial Natriuretic Factor A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. ANF,ANP,Atrial Natriuretic Peptide,Atrial Natriuretic Peptides,Atriopeptins,Auriculin,Natriuretic Peptides, Atrial,ANF (1-126),ANF (1-28),ANF (99-126),ANF Precursors,ANP (1-126),ANP (1-28),ANP Prohormone (99-126),ANP-(99-126),Atrial Natriuretic Factor (1-126),Atrial Natriuretic Factor (1-28),Atrial Natriuretic Factor (99-126),Atrial Natriuretic Factor Precursors,Atrial Natriuretic Factor Prohormone,Atrial Natriuretic Peptide (1-126),Atrial Pronatriodilatin,Atriopeptigen,Atriopeptin (1-28),Atriopeptin (99-126),Atriopeptin 126,Atriopeptin Prohormone (1-126),Cardiodilatin (99-126),Cardiodilatin Precursor,Cardionatrin I,Cardionatrin IV,Prepro-ANP,Prepro-CDD-ANF,Prepro-Cardiodilatin-Atrial Natriuretic Factor,Pro-ANF,ProANF,Proatrial Natriuretic Factor,Pronatriodilatin,alpha ANP,alpha-ANP Dimer,alpha-Atrial Natriuretic Peptide,beta-ANP,beta-Atrial Natriuretic Peptide,gamma ANP (99-126),gamma-Atrial Natriuretic Peptide,Natriuretic Peptide, Atrial,Peptide, Atrial Natriuretic,Peptides, Atrial Natriuretic,Prepro ANP,Prepro CDD ANF,Prepro Cardiodilatin Atrial Natriuretic Factor,Pro ANF,alpha ANP Dimer,alpha Atrial Natriuretic Peptide,beta ANP,beta Atrial Natriuretic Peptide,gamma Atrial Natriuretic Peptide
D001784 Blood Gas Analysis Measurement of oxygen and carbon dioxide in the blood. Analysis, Blood Gas,Analyses, Blood Gas,Blood Gas Analyses,Gas Analyses, Blood,Gas Analysis, Blood
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000860 Hypoxia Sub-optimal OXYGEN levels in the ambient air of living organisms. Anoxia,Oxygen Deficiency,Anoxemia,Deficiency, Oxygen,Hypoxemia,Deficiencies, Oxygen,Oxygen Deficiencies

Related Publications

A Kawashima, and K Kubo, and K Hirai, and S Yoshikawa, and Y Matsuzawa, and T Kobayashi
December 1987, Methods and findings in experimental and clinical pharmacology,
A Kawashima, and K Kubo, and K Hirai, and S Yoshikawa, and Y Matsuzawa, and T Kobayashi
January 1997, Journal of applied physiology (Bethesda, Md. : 1985),
A Kawashima, and K Kubo, and K Hirai, and S Yoshikawa, and Y Matsuzawa, and T Kobayashi
February 1995, The European respiratory journal,
A Kawashima, and K Kubo, and K Hirai, and S Yoshikawa, and Y Matsuzawa, and T Kobayashi
November 1992, Pediatric nephrology (Berlin, Germany),
A Kawashima, and K Kubo, and K Hirai, and S Yoshikawa, and Y Matsuzawa, and T Kobayashi
December 1987, Clinical endocrinology,
A Kawashima, and K Kubo, and K Hirai, and S Yoshikawa, and Y Matsuzawa, and T Kobayashi
January 1986, Klinische Wochenschrift,
A Kawashima, and K Kubo, and K Hirai, and S Yoshikawa, and Y Matsuzawa, and T Kobayashi
October 1989, Journal of cardiothoracic anesthesia,
A Kawashima, and K Kubo, and K Hirai, and S Yoshikawa, and Y Matsuzawa, and T Kobayashi
November 1993, Angiology,
A Kawashima, and K Kubo, and K Hirai, and S Yoshikawa, and Y Matsuzawa, and T Kobayashi
June 2005, Peptides,
A Kawashima, and K Kubo, and K Hirai, and S Yoshikawa, and Y Matsuzawa, and T Kobayashi
January 1991, Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques,
Copied contents to your clipboard!